Hyloris Pharmaceuticals SA banner

Hyloris Pharmaceuticals SA
XBRU:HYL

Watchlist Manager
Hyloris Pharmaceuticals SA Logo
Hyloris Pharmaceuticals SA
XBRU:HYL
Watchlist
Price: 6.34 EUR -3.06% Market Closed
Market Cap: €177.5m

Wall Street
Price Targets

HYL Price Targets Summary
Hyloris Pharmaceuticals SA

Wall Street analysts forecast HYL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HYL is 13.84 EUR with a low forecast of 6.06 EUR and a high forecast of 21.42 EUR.

Lowest
Price Target
6.06 EUR
4% Downside
Average
Price Target
13.84 EUR
118% Upside
Highest
Price Target
21.42 EUR
238% Upside
Hyloris Pharmaceuticals SA Competitors:
Price Targets
MNOV
MediciNova Inc
565% Upside

Revenue
Forecast

113% / Year
Past Growth
110% / Year
Estimated Growth
Estimates Accuracy
-31%
Average Miss
113% / Year
Past Growth
110% / Year
Estimated Growth
Estimates Accuracy
-31%
Average Miss

For the last 6 years the compound annual growth rate for Hyloris Pharmaceuticals SA's revenue is 113%. The projected CAGR for the next 3 years is 110%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HYL's stock price target?
Price Target
13.84 EUR

According to Wall Street analysts, the average 1-year price target for HYL is 13.84 EUR with a low forecast of 6.06 EUR and a high forecast of 21.42 EUR.

What is Hyloris Pharmaceuticals SA's Revenue forecast?
Projected CAGR
110%

For the last 6 years the compound annual growth rate for Hyloris Pharmaceuticals SA's revenue is 113%. The projected CAGR for the next 3 years is 110%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett